MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
125 hedge funds and large institutions have $2.34B invested in MyoKardia, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 121 → 125 (+4)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
125
Holding in Top 10
7
Calls
$6.24M
Puts
$2.13M
Top Buyers
| 1 | +$48.3M | |
| 2 | +$14.7M | |
| 3 | +$9.66M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$9.55M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.68M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$15.8M | |
| 3 | -$9.41M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$8.18M |
| 5 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$8.05M |